|
TCF19 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.604200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.931600E-01 |
| Normal-vs-Stage2 |
7.110200E-01 |
| Normal-vs-Stage3 |
3.179800E-02 |
| Normal-vs-Stage4 |
3.768000E-01 |
| Stage1-vs-Stage2 |
7.287800E-01 |
| Stage1-vs-Stage3 |
2.602100E-02 |
| Stage1-vs-Stage4 |
4.631000E-01 |
| Stage2-vs-Stage3 |
2.481600E-02 |
| Stage2-vs-Stage4 |
6.125600E-01 |
| Stage3-vs-Stage4 |
1.603800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.461200E-01 |
| Normal-vs-AfricanAmerican |
4.740200E-01 |
| Normal-vs-Asian |
8.169800E-01 |
| Caucasian-vs-AfricanAmerican |
6.582200E-01 |
| Caucasian-vs-Asian |
8.410200E-01 |
| AfricanAmerican-vs-Asian |
9.728200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.602200E-01 |
| Normal-vs-Female |
6.272800E-01 |
| Male-vs-Female |
9.087800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.990400E-01 |
| Normal-vs-Extreme_Weight |
9.598000E-01 |
| Normal-vs-Obese |
1.383050E-01 |
| Normal-vs-Extreme_Obese |
4.451000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.078000E-01 |
| Normal_Weight-vs-Obese |
2.943700E-02 |
| Normal_Weight-vs-Extreme_Obese |
6.630000E-01 |
| Extreme_Weight-vs-Obese |
7.809900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.376400E-01 |
| Obese-vs-Extreme_Obese |
1.159230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.297200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.499560E-01 |
| Normal-vs-Age(61-80Yrs) |
8.881400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.859600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.348000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.304000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.561800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.708000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.998400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.836800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.230200E-01 |
| Normal-VS-Type2 PRCC |
4.499400E-01 |
| Normal-VS-KIRP CIMP |
6.956200E-01 |
| Normal-VS-Unclassified PRCC |
4.426400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.327000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.699200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.523600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.105200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.810800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.859600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.181000E-01 |
| Normal-vs-N1 |
1.107800E-01 |
| Normal-vs-N2 |
2.654200E-01 |
| N0-vs-N1 |
7.681600E-02 |
| N0-vs-N2 |
4.461000E-01 |
| N1-vs-N2 |
1.590430E-02 |
|
|
